The study found that RBCK1 mutated in all 19 cancers, with the frequency of variation exceeding 5% in 15 tumor types, 10% in 11, 15% in 4, 20% in 2, and >25% in COAD (Figure 3A). The gene discussed is RBCK1; the disease is neoplasm.